Written by Doug Weiss | Updated on Mar 29, 2023
To start off 2023, below are 23 notable stories relating to Gallus’s thought leadership.
Addiction & Substance Use
In-depth Conversation About Substance Abuse Following Matthew Perry Interview
Fox10 Phoenix, AZ Morning Show Live Appearance at Gallus Medical Detox Centers
Highlighting ‘Recovery Month’ with Gallus Medical Detox Centers
Combating Substance Abuse in the LBGTQ+ Community
Local Nurse Celebrates National Nurses Week Remembering Mom, Nurses’ Advocate
Mental Health
Mental Health Expert Talks About Dealing with Trauma
Fentanyl Crisis
Inside Colorado’s Devastating Fentanyl Crisis
Law Enforcement Warns Rainbow Fentanyl in Colorado
Warning to Parents About Rainbow Fentanyl Pills, Colorado Springs School Districts Take Action
DEA: Fentanyl Pills/Powders Made to Look Like Candy Target Youngsters
Steve Carleton Joins 9NEWS To Talk About Fentanyl Overdose
Fentanyl Prosecutions, Seizures Up as Crisis Grows
Treatments for Fentanyl Addiction
Specialist Discusses Dangers of Fentanyl, and how to get help
“Test everything you consume”: How to test for fentanyl
Suburban America grappling with drug use more than ever before
Prescription Drugs & Benzodiazepines
From Ankle Injury to Opioid Abuse to Recovery: One Woman’s Story
Steve Carleton, LCSW talks about prescription medication addiction
Certified addiction specialist in Colorado discusses Benzodiazepines
Steve Carleton, Gallus Executive Clinical Director, Discusses Fentanyl on CNN
Health Officials Urge Parents to Talk to Kids About the Dangers of Drugs on Overdose Awareness Day
If you or someone you know is struggling with substance use, please call our expert team today to learn more about how Gallus can help: 888-306-3122
Are you or someone you love struggling with substance abuse?
Contact Us
Doug Weiss
Doug is a successful PE portfolio, Inc 5,000 and Fortune 250 executive with over 30 years of experience in consumer-focused, market-driven companies in consumer services, healthcare and business services (loyalty, insurance) verticals. Doug has served as a C-suite executive for the last 20 years, with a track record of driving profitable growth demonstrated by four successful go private and recap exits of 20%+ share price and 15X+ EBITDA. Doug has a proven track record in leading multi-site healthcare leadership in: eating disorders, 28 programs, 5,500 patients; primary care, 38 locations 1MM visits; infertility, 45 locations, 25% of IVF in US; Cosmetic Surgery, 48 locations; Vein Therapy, 58 locations; Massage, 78 locations. Doug holds a BA, cum laude, from Middlebury College, an MBA in Healthcare Management from The University of Connecticut and has completed several executive education programs at Harvard Business School and Dartmouth’s Tuck School.
Steve Carleton 